{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:27:25Z","timestamp":1792661245865,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1093\/infdis\/jir349","type":"journal-article","created":{"date-parts":[[2011,10,10]],"date-time":"2011-10-10T22:54:28Z","timestamp":1318287268000},"page":"S1075-S1081","source":"Crossref","is-referenced-by-count":201,"title":["Recombinant Vesicular Stomatitis Virus\u2013Based Vaccines Against Ebola and Marburg Virus Infections"],"prefix":"10.1093","volume":"204","author":[{"given":"Thomas W.","family":"Geisbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"key\n\t\t\t\t20170702150324_bib1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/viro.1998.9367","article-title":"Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates","volume":"251","author":"Hevey","year":"1998","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170702150324_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","article-title":"Development of a preventive vaccine for Ebola virus infection in primates","volume":"408","author":"Sullivan","year":"2000","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170702150324_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","article-title":"Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates","volume":"424","author":"Sullivan","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170702150324_bib4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170702150324_bib5","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1128\/JVI.00959-06","article-title":"Cross-protection against Marburg virus strains using a live, attenuated recombinant vaccine","volume":"80","author":"Daddario-DiCaprio","year":"2006","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib6","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1371\/journal.pmed.0030177","article-title":"Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs","volume":"3","author":"Sullivan","year":"2006","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170702150324_bib7","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1128\/JVI.00105-07","article-title":"Successful topical respiratory tract immunization of primates against Ebola virus","volume":"81","author":"Bukreyev","year":"2007","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib8","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.1086\/520583","article-title":"Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge","volume":"196","author":"Warfield","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702150324_bib9","doi-asserted-by":"crossref","first-page":"6894","DOI":"10.1016\/j.vaccine.2008.09.082","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses","volume":"26","author":"Geisbert","year":"2008","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170702150324_bib10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/CVI.00431-07","article-title":"Vaccine to confer complete protection against multistrain Ebola and Marburg virus infections","volume":"15","author":"Swenson","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170702150324_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/14760584.7.4.417","article-title":"Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses","volume":"7","author":"Swenson","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20170702150324_bib12","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1128\/JVI.00561-09","article-title":"Single injection vaccine protects nonhuman primates against Marburg virus and three species of Ebola virus","volume":"83","author":"Geisbert","year":"2009","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib13","doi-asserted-by":"crossref","first-page":"e5447","DOI":"10.1371\/journal.pone.0005547","article-title":"Mucosal immunization of cynomolgus macaques with the VSVDeltaG\/ZEBOV GP vaccine stimulates strong Ebola GP-specific immune responses","volume":"4","author":"Qiu","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170702150324_bib14","doi-asserted-by":"crossref","first-page":"10386","DOI":"10.1128\/JVI.00594-10","article-title":"Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburgvirus in nonhuman primates","volume":"84","author":"Geisbert","year":"2010","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib15","doi-asserted-by":"crossref","first-page":"e1000904","DOI":"10.1371\/journal.ppat.1000904","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus species","volume":"6","author":"Hensley","year":"2010","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170702150324_bib16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1128\/CVI.00467-09","article-title":"Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector","volume":"17","author":"Pratt","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20170702150324_bib17","first-page":"645","article-title":"Filoviridae","volume-title":"Virus taxonomy: Eighth report of the International Committee on Taxonomy of Viruses","author":"Feldmann","year":"2004"},{"key":"key\n\t\t\t\t20170702150324_bib18","first-page":"1409","article-title":"Filoviridae: Marburg and Ebola Viruses","volume-title":"Fields virology","author":"Sanchez","year":"2006","edition":"5th ed"},{"key":"key\n\t\t\t\t20170702150324_bib19","doi-asserted-by":"crossref","first-page":"e1000212","DOI":"10.1371\/journal.ppat.1000212","article-title":"Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda","volume":"4","author":"Towner","year":"2008","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170702150324_bib20","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(95)90925-7","article-title":"Isolation and partial characterisation of a new strain of Ebola virus","volume":"345","author":"Le Guenno","year":"1995","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170702150324_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-1-4684-7032-1_4","article-title":"Rhabdovirus genomes and their products","volume-title":"The Rhabdoviruses","author":"Rose","year":"1987"},{"key":"key\n\t\t\t\t20170702150324_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2105\/AJPH.47.2.205","article-title":"Epizootiology of vesicular stomatitis","volume":"47","author":"Brandly","year":"1957","journal-title":"Am J Pub Health"},{"key":"key\n\t\t\t\t20170702150324_bib23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4269\/ajtmh.1966.15.244","article-title":"Clinical and serological response to laboratory-acquired human infection by Indiana type vesicular stomatitis virus (VSV)","volume":"15","author":"Johnson","year":"1966","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170702150324_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/oxfordjournals.aje.a120721","article-title":"Vesicular stomatitis virus in Panama. Human serologic patterns in a cattle raising area","volume":"86","author":"Brody","year":"1967","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170702150324_bib25","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib26","doi-asserted-by":"crossref","first-page":"9317","DOI":"10.1128\/JVI.78.17.9317-9324.2004","article-title":"Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses","volume":"78","author":"Publicover","year":"2004","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib27","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/JVI.01911-06","article-title":"Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations","volume":"81","author":"Clarke","year":"2007","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170702150324_bib29","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies virus from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20170702150324_bib30","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/JVI.75.9.4430-4434.2001","article-title":"Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates","volume":"75","author":"McGettigan","year":"2001","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib31","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1128\/JVI.75.18.8724-8732.2001","article-title":"Expression and immunogenicity of human immunodeficiency virus type 1 gag expressed by a replication-competent rhabdovirus-based vaccine vector","volume":"75","author":"McGettigan","year":"2001","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/viro.2001.1212","article-title":"Live and killed rhabdovirus-based vectors as potential hepatitis C vaccines","volume":"292","author":"Siler","year":"2002","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170702150324_bib33","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1128\/JVI.71.8.5982-5989.1997","article-title":"High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses","volume":"71","author":"Kretzschmar","year":"1997","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib34","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170702150324_bib35","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","article-title":"Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge","volume":"72","author":"Roberts","year":"1998","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib36","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1073\/pnas.93.21.11359","article-title":"Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles","volume":"93","author":"Schnell","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170702150324_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00686075","article-title":"Role of VSV G antigen in the development of experimental spongiform encephalopathy in mice","volume":"70","author":"Robain","year":"1986","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170702150324_bib38","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1128\/JVI.76.3.1309-1327.2002","article-title":"Relative neurotropism of a recombinant rhabdovirus expressing a green fluorescent envelope glycoprotein","volume":"76","author":"van den Pol","year":"2002","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib39","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1128\/JVI.77.14.8039-8047.2003","article-title":"Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host","volume":"77","author":"Martinez","year":"2003","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib40","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib41","doi-asserted-by":"crossref","first-page":"S404","DOI":"10.1086\/520591","article-title":"Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever","volume":"196","author":"Jones","year":"2007","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702150324_bib42","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: An efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170702150324_bib43","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","article-title":"Effective post-exposure treatment of Ebola infection","volume":"3","author":"Feldmann","year":"2007","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170702150324_bib44","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/JVI.00456-08","article-title":"Recombinant vesicular stomatitis virus vector mediates post-exposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates","volume":"82","author":"Geisbert","year":"2008","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20170702150324_bib45","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3201\/eid1607.100159","article-title":"Postexposure treatment of Marburg virus infection","volume":"16","author":"Geisbert","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170702150324_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2006.10.026","article-title":"Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates","volume":"360","author":"Johnson","year":"2007","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170702150324_bib47","doi-asserted-by":"crossref","first-page":"e1000225","DOI":"10.1371\/journal.ppat.1000225","article-title":"Vesicular stomatitis virus-based Ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates","volume":"4","author":"Geisbert","year":"2008","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170702150324_bib48","first-page":"897","article-title":"Vesicular stomatitis","volume-title":"Diseases transmitted from animals to man, 6th ed","author":"Tesh","year":"1975"},{"key":"key\n\t\t\t\t20170702150324_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jir298","article-title":"Management of an accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany","author":"Gunther","year":"2011","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170702150324_bib50","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2741\/2767","article-title":"Measles vaccines","volume":"13","author":"Griffin","year":"2008","journal-title":"Front Biosci"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/204\/suppl_3\/S1075\/18083463\/jir349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T20:23:09Z","timestamp":1593116589000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article-lookup\/doi\/10.1093\/infdis\/jir349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":50,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2011,11,1]]},"published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jir349","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}